SL Bionics Secures Additional 3.7 Billion KRW Stake in Studio Santa Claus

[Asia Economy Reporter Jang Hyowon] SL Bionics announced on the 17th that it exercised the conversion rights of the 5th series convertible bonds worth 3.7 billion KRW of its subsidiary ‘Studio Santa Claus,’ converting 376,322 shares to strengthen its governance structure and generate investment returns.

SL Bionics is expected to increase its holdings in Studio Santa Claus from 1,251,113 shares (15.69%) to 1,627,435 shares (20.41%) by acquiring an additional 376,322 new shares through the exercise of the conversion rights of the 5th series convertible bonds (CB) of Studio Santa Claus.

The scale of shares acquired by SL Bionics amounts to 3.7 billion KRW, and the newly acquired shares are scheduled to be listed on the 28th.

Studio Santa Claus is a comprehensive entertainment company that recently produced the Netflix series ‘My Name,’ which secured the global No. 2 spot, and gained attention by distributing the global action blockbuster ‘355’ domestically, which is set to be released in February. The company has also announced plans to diversify its OTT content production and distribution business by preparing new businesses in NFT and metaverse sectors.

An SL Bionics official stated, “The recent decision was made based on the expectation of continuous profit generation through entry into Studio Santa Claus’s NFT and metaverse-related businesses,” adding, “We will secure business diversification and financial stability through expanding our shareholding ratio and cooperation between the two companies.”

Meanwhile, SL Bionics secured approximately 13.8 billion KRW in subscription deposits through a general public offering of forfeited shares after a rights offering to shareholders on the 12th.

This content was produced with the assistance of AI translation services.